- Adequate laboratory parameters: absolute neutrophil count >1000 cells/mm3 hemoglobin >9.0 g/dL; platelets >75,000/mm3; creatinine <1.5 x upper limit of normal; SGOT/SGPT <3.0 x upper limit of normal; bilirubin <2.0 mg/dL. Note: Patients who are taking indinavir or atazanavir will be allowed on this trial if their bilirubin is >3.0 mg/dL and if it is deemed by both the Principal Investigator and patient's physician that the elevated bilirubin is solely related to indinavir or atazanavir.